Skip to Main Content

Author Details

Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
1989
264
44
PMIDPaper TitleJournal TitlePublished Year
37414703Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.Eur Urol2024
38061427Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.Ann Oncol2024
36331157Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study).J Urol2023
38046899Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's "big data for better outcomes" program.Int J Surg Protoc2023
37286165[Depressed skull fracture presenting a cookie-cutter aspect with a Malmström ventouse: A case report and review of the literature].Gynecol Obstet Fertil Senol2023
37117107Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.Eur Urol2023
37003085Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.Eur J Cancer2023
36813168ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.Radiother Oncol2023
36737297Systematic Biopsies as a Complement to Magnetic Resonance Imaging-targeted Biopsies: "To Be or Not To Be"?Eur Urol2023
36639296Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.Eur Urol2023
36494221Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.Eur Urol2023
34147405Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.Eur Urol Focus2022
35440417Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11].Eur Urol2022
35697600EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy.Eur Urol Oncol2022
35724759Tranexamic acid for the prevention of blood loss after cesarean among women with twins: a secondary analysis of the TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery randomized clinical trial.Am J Obstet Gynecol2022
35562268TNM Staging of Prostate Cancer: Challenges in Securing a Globally Applicable Classification.Eur Urol2022
35450732Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.Eur Urol2022
35999118A Plea for Economically Sustainable Evidence-based Guidelines.Eur Urol2022
35985901Prostate Cancer Detection Percentages of Repeat Biopsy in Patients with Positive Multiparametric Magnetic Resonance Imaging (Prostate Imaging Reporting and Data System/Likert 3-5) and Negative Initial Biopsy. A Mini Systematic Review.Eur Urol2022
36291905A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology.Cancers (Basel)2022
36008748Management of Biochemical Recurrence of Prostate Cancer After Curative Treatment: A Focus on Older Patients.Drugs Aging2022
33691580Assisted vaginal birth with the Odon Device<sup>TM</sup>.J Matern Fetal Neonatal Med2022
35184906Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium.Eur Urol2022
34980492Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.Eur Urol2022
35094898Modern Imaging in Prostate Cancer: Do We Treat Patients, or Their Scans?Eur Urol2022
34998681[Geriatric assessment and treatment of nonmetastatic muscle-invasive bladder cancer in patients over 75 years of age. Retrospective and multicentric study of 121 cases].Prog Urol2022
34500133[Information tool about labor and delivery designed by Delphi method].Gynecol Obstet Fertil Senol2022
34785188Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.Eur Urol Oncol2022
34844839Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings.Eur J Cancer2022
34481098[Demelin's maneuver for arm entrapment during vaginal breech delivery].Gynecol Obstet Fertil Senol2022
34020930Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?Eur Urol Oncol2022
33967010Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.Eur Urol Focus2022
32643031Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts.World J Urol2021
33574012Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature.Eur Urol Oncol2021
33791843Asymmetric pelvis and term breech presentation: is planned vaginal delivery still a safe option?Arch Gynecol Obstet2021
34467236TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes.Eur Urol Open Sci2021
34775896Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy.Int J Hyperthermia2021
33962808A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.Eur Urol2021
34230507Maternal outcomes and risk factors for COVID-19 severity among pregnant women.Sci Rep2021
34283029Presence of Urinary Exosomes for Liquid Biopsy of Clear Cell Renal Cell Carcinoma: Protocol for a Pilot Feasibility Study.JMIR Res Protoc2021
33172724EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.Eur Urol2021
33172721European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate Biopsy.Eur Urol2021
33423943A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.Eur Urol Oncol2021
33069912Intra pelvic spontaneous rotation of persistent occiput posterior position in case of operative vaginal delivery with spatulas.J Gynecol Obstet Hum Reprod2021
33039206EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.Eur Urol2021
32617640Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.Eur J Nucl Med Mol Imaging2021
30946523Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trial.BJU Int2020
32001144Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.Eur Urol2020
32057720Management of bladder cancer in older patients: Position paper of a SIOG Task Force.J Geriatr Oncol2020
31882267[Management of residual masses of testis germ cell tumors].Bull Cancer2020
  • 1 - 50 of 264

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 9
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 6
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 7
University of Oxford
Career Start Year 2007
Number of shared co-authors 10
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 14
University of California San Diego
Career Start Year 2005
Number of shared co-authors 1
Winterthur Cantonal Hospital
Career Start Year 2005
Number of shared co-authors 4
Bristol Urological Institute, Southmead Hospital
Career Start Year 2004
Number of shared co-authors 8
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 7
Cambridge University Hospitals NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 7
Saarland University
Career Start Year 2000
Number of shared co-authors 2
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 14
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
Queen's University
Career Start Year 1996
Number of shared co-authors 6
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 1996
Number of shared co-authors 13
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 26
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 16
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 4
University of Toronto
Career Start Year 1989
Number of shared co-authors 33
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 3
University of Melbourne
Career Start Year 1988
Number of shared co-authors 7
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 12
PolyClinic St. Moritz/Scuol
Career Start Year 1986
Number of shared co-authors 4
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 45
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 28
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 10
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 21
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 15
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 22
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 35

Collaborators

Liverpool University Hospitals
Co-authored papers 29
University Health Network, University of Toronto
Co-authored papers 23
St. Antonius Hospital
Co-authored papers 21
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 16
IRCCS San Raffaele Scientific Institute
Co-authored papers 14
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Co-authored papers 14
universite Grenoble-Alpes (UGA)
Co-authored papers 12
Tulane University School of Medicine
Co-authored papers 10
Houston Methodist Cancer Center
Co-authored papers 9
Skane University Hospital, Lund University
Co-authored papers 9
Meyer Cancer Center, Englander Institute for Precision Medicine
Co-authored papers 8
University of Aberdeen
Co-authored papers 8
University Hospitals Leuven
Co-authored papers 8
The Institute of Cancer Research
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
University of California Davis
Co-authored papers 7
The Institute for Cancer Research
Co-authored papers 7
Ghent University, GZA Ziekenhuizen
Co-authored papers 7
Dana-Farber Cancer Institute
Co-authored papers 7
University of British Columbia
Co-authored papers 7
University of Montreal Health Center
Co-authored papers 7
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
University of California san francisco
Co-authored papers 6
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 6
Radboud University Medical Center
Co-authored papers 6
University of Toronto
Co-authored papers 6
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 6
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Monash University
Co-authored papers 6